Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

With the only FDA-approved treatment off the market, the FDA is looking for ideas for development of new preterm birth treatments.

preterm birth
The FDA/Duke-Margolis meeting on preterm birth drug development is scheduled for late January. • Source: Shutterstock

More from R&D

More from Conferences